Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.66142 | 87 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.0563 | 89 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.49611 | 86 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.9625 | 88 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.68719 | 87 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.89816 | 90 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.33827 | 86 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.33034 | 85 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.63274 | 87 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.25487 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.21508 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.51386 | 86 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.01527 | 83 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.33031 | 85 |